Lagoda Investment Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Transmedics
TMDX
|
+$1.63M |
| 2 |
Trupanion
TRUP
|
+$529K |
| 3 |
RXO
RXO
|
+$145K |
| 4 |
Ubiquiti
UI
|
+$102K |
| 5 |
Eaton
ETN
|
+$55.2K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$7.82M |
| 2 |
Natera
NTRA
|
+$1.43M |
| 3 |
Texas Pacific Land
TPL
|
+$1.31M |
| 4 |
Royalty Pharma
RPRX
|
+$1.06M |
| 5 |
Corpay
CPAY
|
+$947K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.19% |
| 2 | Energy | 21.84% |
| 3 | Industrials | 16.55% |
| 4 | Financials | 15.4% |
| 5 | Healthcare | 14.47% |
Similar funds
Lagoda Investment Management's Q4 2023 Portfolio in Review
As of Q4 2023, Lagoda Investment Management held 42 positions worth $147M, down 3.5% from $152M the previous quarter. Its ten largest holdings account for 78% of the portfolio.
Lagoda Investment Management withdrew a net $13M in Q4 2023, closing 3 positions and reducing 15 holdings. Its most notable exit was Seagen Inc. Common Stock, an estimated $7.82M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Energy and Industrials.
Against the trend, Lagoda Investment Management added an estimated $1.63M to Transmedics.
- Lagoda Investment Management added most to Transmedics in Q4 2023, an estimated $1.63M increase.
- Lagoda Investment Management's biggest Q4 2023 reduction was Natera, cutting an estimated $1.43M.
- Lagoda Investment Management fully exited Seagen Inc. Common Stock in Q4 2023, selling an estimated $7.82M.
- Lagoda Investment Management's ten largest holdings make up 78% of its $147M portfolio in Q4 2023.
- Lagoda Investment Management opened 0 new positions and closed 3 in Q4 2023.
- Lagoda Investment Management's portfolio value fell 3.5% quarter-over-quarter to $147M.
Based on Lagoda Investment Management's 13F filing for Q4 2023, filed 14 Feb 2024.